Antiviral Meds Could Help Ease or Prevent Type 1 Diabetes in Kids, Study Finds
WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Recent research has suggested that viruses could play a role in the loss of pancreatic beta cells, which triggers type 1 diabetes. Now, a new trial finds antiviral medications, when given soon after a child …
Learn MoreTea Drinkers May Gain Better Blood Sugar Control
TUESDAY, Oct. 3, 2023 (HealthDay News) — Drinking dark tea daily may help balance blood sugar levels and stave off type 2 diabetes, the form of the disease most closely tied to obesity.This is the main message from a new study that looked at tea-drin…
Learn MoremHealth-Delivered Coaching Cuts Blood Glucose Levels in Patients With Diabetes
TUESDAY, Oct. 3, 2023 (HealthDay News) — A clinical pharmacist and health coach-delivered mobile health intervention can improve blood glucose levels in African American and Latinx populations, according to a study published online Sept. 29 in JAMA N…
Learn MoreThreshold of Diabetes Diagnosis May Be Too High for Women Under 50
TUESDAY, Oct. 3, 2023 (HealthDay News) — Women aged younger than 50 years have a markedly lower hemoglobin A1c (HbA1c) distribution than men, according to a study published online Sept. 30 in Diabetes Therapy to coincide with the annual meeting of th…
Learn MoreHbA1c Higher in Black Youth With Type 1 Diabetes Versus White Youth
MONDAY, Oct. 2, 2023 (HealthDay News) — Young Black patients with type 1 diabetes have clinically relevant higher average hemoglobin A1c (HbA1c) at any given level of mean blood glucose level than White patients, according to a study published online…
Learn MoreDiabetes Could Speed Progression of Blood Cancer Myeloma
MONDAY, Oct. 2, 2023 (HealthDay News) — Diabetes may accelerate the growth of a blood cancer known as multiple myeloma, affecting overall survival, according to a new study.The research, published Sept. 29 in the journal Blood Advances, also undersco…
Learn MoreLa FDA agrega advertencia a la etiqueta de Ozempic sobre el riesgo de obstrucción intestinal
JUEVES, 28 de septiembre de 2023 (HealthDay News) — Ozempic, un medicamento para la diabetes tipo 2 que se ha utilizado cada vez más para ayudar en la pérdida de peso, ahora estará etiquetado como posible causante de obstrucción intestinal.La Adminis…
Learn MorePharmacist-Led Intervention Lowers HbA1c in Type 2 Diabetes
THURSDAY, Sept. 28, 2023 (HealthDay News) — A pharmacist-led intervention (UCMyRx) can result in a significant reduction in hemoglobin A1c (HbA1c) concentration among Hispanic patients with type 2 diabetes (T2D), according to a study published online…
Learn More